Blaine Pharmaceuticals Honored as Finalist in 2007 JPMA Innovation Awards
Share:
CINCINNATI, April 12 // -- Blaine Pharmaceuticals has been recognized for its outstanding work in creating ReliaDose(R), a revolutionary medicine delivery system for babies. The company was chosen as a finalist in the 2007 JPMA Innovation Awards competition that highlights some of the most exciting new products in the marketplace today.
"We are honored that JPMA has nominated us as a finalist and acknowledged our product's potential to have a positive impact on the industry," said Dreama Kirby, chief marketing officer, Blaine Pharmaceuticals. "We think ReliaDose(R) is a perfect solution to the age-old problem of giving medicine to infants and that it will revolutionize the way medicine is administered."
Invented by a mom, ReliaDose(R) is specifically designed to work with a child's natural desire to feed while ensuring complete, easy, and gentle dosing of prescribed and OTC liquid medications. ReliaDose(R) features a patented medicine delivery system that includes a dual-chamber nipple, bottle, and syringe that work together to mask the taste of medicine while ensuring safe, accurate dosing every time.
This year's winners will be announced during the opening ceremonies of the 2007 International JPMA Trade Show on Monday, April 23. Each year, more than 100 exhibiting companies enter their most cutting-edge products into the competition, but only 10 are selected as winners. Entries are evaluated by a selection committee of trade media representatives and industry retail buyers, and judged on their innovation, marketability, trend-setting potential, appeal, and usefulness.
About JPMA
The Juvenile Products Manufacturers Association, Inc. is an international trade organization of 400 member companies in the United States, Canada, and Mexico dedicated to promoting the industry and the safe use of juvenile products.
About Blaine Pharmaceuticals
Blaine Pharmaceuticals, founded in 1955, specializes in the development and acquisition of consumer brands with significant value and unrealized potential. Blaine builds sustainable brands by creating consumer demand through recommendations from healthcare professionals. The company's flagship product, Mag-Ox 400(R), is the most recommended magnesium supplement by healthcare professionals. Other products include the DiaSense(R) family of nutritional supplements, and ReliaDose(R), a pediatric medicine delivery system.
Blaine is committed to cultivating relationships with physicians, pharmacists, patients, wholesalers, retailers, and business partners to build brands and lay the foundation for future endeavors. For more information, visit www.blainepharma.com.
Source: Blaine Pharmaceuticals
CONTACT: Bethany Flick of Blaine Pharmaceuticals, +1-859-344-9600, ext.
29, bflick@blainepharma.com
Web site: www.blainepharma.com/
